Stereotactic radiosurgery is an increasingly used and the least invasive surgical option for patients with medically refractory trigeminal neuralgia (TN). The authors began use of this technique at our center in 1992 and have evaluated outcomes serially. Independently acquired data from 220 patients with idiopathic TN that had Gamma Knife radiosurgery was reviewed. The median radiosurgery dose was 80 Gy with a range of 60 to 90 Gy. Most patients had features of typical TN, although 16 (7.3%) described additional atypical features. One hundred thirty-five patients (61.4%) had prior surgery. Patients were followed to a maximum of 6.5 years (median, 2 years). Complete or partial pain relief was achieved in 85.6% of patients at 1 year. Complete pain relief was achieved in 64.9 % of patients at 6 months, 70.3% at 1 year, and 75.4% patients at 33 months. Patients with an atypical pain component had a lower rate of achieving pain relief (p ‫ס‬ 0.025). Due to recurrences, 55.8% of patients had complete or partial pain relief at 5 years. The absence of preoperative sensory disturbance or prior surgery correlated with an increased proportion of patients in complete or partial pain relief over time. Ten percent of patients developed new or increased subjective facial paresthesia or facial numbness. Radiosurgery for idiopathic TN was safe and effective, and provided benefit to a patient population with a high frequency of prior surgical intervention. It is an important addition to the surgical armamentarium for TN.
Although most patients respond to medical therapy as the initial treatment of trigeminal neuralgia (TN), many over time experience a pain relapse. Others cannot tolerate medical therapy, and eventually require surgical intervention. Although often associated with initial pain relief, all surgical procedures have variable but definite rates of recurrence and morbidity. Gamma knife radiosurgery has been advocated as a minimally invasive alternative surgical approach to microvascular decompression (MVD) or percutaneous surgeries. Although the use of trigeminal radiosurgery has grown steadily since 1992, stereotactic irradiation of the trigeminal ganglion was first reported by Leksell in 1971. 1 More recently, several authors have reported their initial results with radiosurgery using high-resolution image guidance. [2] [3] [4] [5] [6] [7] [8] [9] This data testified to the accuracy of radiosurgical targeting, the initial safety of the technique, and provided dose-response information. As increasing numbers of patients were treated, we reviewed our clinical outcomes after radiosurgery. This report discusses indications, technical issues, results, and biology of the procedure.
TECHNIQUE OF RADIOSURGERY
Presently, we have performed radiosurgery in 450 patients at the University of Pittsburgh. The results reported in this paper stemmed from a review of the first 220 patients published recently. 10 The model A and B gamma knife units were used interchangeably for radiosurgery at our center. After application of the Leksell model G stereotactic frame (Elekta Instruments, Atlanta, GA, U.S.A.) under local anesthesia, the patients underwent stereotactic magnetic resonance imaging to identify the trigeminal nerve. Rare patients had computed tomography imaging for targeting if they could not undergo magnetic resonance imaging. Magnetic resonance imaging was performed using contrast-enhanced, shortrepetition-time sequences and axial volume acquisitions of 512 × 216 matrices divided into 1-mm slices. A single 4-mm isocenter was used in the majority of patients. Some had radiosurgical volumes created with two 4-mm isocenters as part of a randomized trial to evaluated the effect of nerve length on clinical outcome. At present we continue to use a single isocenter, targeted 2 to 4 mm anterior from the junction of the trigeminal nerve and pons. The isocenter was usually located so that brain stem surface was irradiated at the 20-to-30% isodose line ( Fig. 1 ). We administered maximum doses of 60 Gy (2.7%), 70 Gy (24.1%), 75 Gy (21.8%), 80 Gy (48.6%), 85 Gy (1.8%), and 90 Gy (0.9%). Patients were discharged from the hospital within 24 hours.
METHOD OF PATIENT EVALUATION
All serial follow-up information was obtained from the patients or their referring physicians regarding the degree of pain relief, latency interval to pain relief, need for further surgical procedures, use of medication, and complications. We updated our clinical information for all 220 patients with a telephone interview by physicians who were not involved in treatment. 10 To evaluate effectiveness over time (besides the typical measure of the proportion of patients with pain relief at initial or last follow-up), we calculated the time to initial response from radiosurgery and the duration of pain relief using the product limit method of Kaplan and Meier. 11 The time to onset of complications after radiosurgery (new or increased sensory disturbance) was calculated using the same methods. Pain relief duration was calculated from the time when the level of pain relief being studied (complete or >50%) was achieved. We correlated outcomes (time to initial response, duration of benefit, and complications) with treatment parameters that included sex, age, duration of symptoms, presence or absence of preoperative paresthesia or additional atypical features, number of prior surgeries, maximum dose, and number of isocenters, using stepwise (forward conditional) multivariate analyses and the Cox proportional hazards model.
UNIVERSITY OF PITTSBURGH EXPERIENCE
The first 264 of our total 450 patient experience for TN were studied last year. 10 Of these first 264 procedures, 25 were performed for nonidiopathic TN (19 were associated with multiple sclerosis, 3 were secondary to tumors, and 3 were secondary to other pathological conditions such as herpetic infection, Lyme disease, or Wallenberg syndrome). These 25 procedures were excluded from this study. Two hundred thirty-nine procedures were performed for idiopathic TN, and 19 were a repeat radiosurgery after an initially successful procedure. For these 19 patients, the outcome after initial radiosurgery was included in this study as a poor result (subsequent outcomes of the repeat procedure were excluded). Thus, 220 procedures in 220 patients were available for analysis. All 220 patients had TN that was idiopathic, long standing, and refractory to medication therapy such as carbamazepine, phenytoin, baclofen, or gabapentin, as well as a variety of analgesic medications.
In these 220 patients (94 men, 126 women), the median age was 70 years (range: 26-92). Most of the patients had long histories of medical treatment, with the median symptom duration of 96 months (range: 3-564 months). Pain was predominantly distributed in the V2 and V3 distributions of the trigeminal nerve (29.5%), followed by V2 alone (22.3%) and V3 alone (13.2%). Patients with first division pain often had radiosurgery as an alternative to other procedures. Although all patients reported the typical trigeminal neuralgia features of a sharp, lancinating or shooting electric-shock type of pain triggered by a variety of events, 16 (7.3%) reported additional features such as a more constant dull, aching, or burning pain. Eighty patients (36.4%) had some sensory disturbance (usually paresthesias) preoperatively, and 3 patients (1.4%) had partial deafferentation pain caused by prior ablative procedures. The preoperative characteristics of our patients are summarized in Table 1 .
Prior surgery was performed in 135 patients (61.4%), including MVD, glycerol rhizotomy, radiofrequency rhizotomy, balloon microcompression, peripheral neurectomy, or ethanol injections ( Table 2 ). In these 135 patients, 86 (39.1%) had 1, 39 (17.7%) had 2, and 10 (4.5%) had 3 or more procedures before radiosurgery. The majority of patients therefore represented both medical and surgical failures. In the remaining 85 patients (38.6%), radiosurgery was the first surgical procedure performed.
CLINICAL OUTCOMES

Pain relief
We subdivided clinical results into 4 categories: excellent, good, fair, and poor. Complete pain relief without the use of any medication was defined as an excellent outcome. We recommended all patients with complete pain relief to taper off their medications (some refused to taper off because of the fear of a recurrence). Those patients with complete pain relief but who were still using some medication were considered as good outcomes. Patients with partial pain relief (more than 50% pain relief) were considered to have a fair outcome. 2 No pain relief or less than 50% pain relief was considered as poor. Placement within a category was decided by the patient rather than by the physician. Criteria for improvement included a reduction in both the frequency and severity of pain attacks. Of the 220 patients, 47 (25.1%) required further additional surgical procedures because of poor pain control. These patients were considered as treatment failures (poor outcome), and the results after the additional procedure were excluded from this analysis. Thus, although outcomes in 220 patients were calculated using actuarial statistics over a 6.5-year period, the median follow-up duration was 2 years (median, 22; range, 6-78 months). Most of the patients responded to radiosurgery within 6 months of the procedure (median, 2 months). The first evaluation was performed for all patients within 6 months after radiosurgery. At the initial follow-up assessment, excellent results were obtained in 105 patients (47.7%), and excellent plus good results were found in 139 patients (63.2 %). More than 50% pain relief (excellent, good, or fair) was noted in 181 patients (82.3%). At the last follow-up evaluation, 88 patients (40%) had excellent outcomes, 121 patients (55.9%) had excellent plus good outcomes, and 152 were fair or better (69.1%). Thirty patients (13.6%) had recurrence of pain after the initial achievement of pain relief (25 patients after complete relief, 5 patients after more than 50% relief) between 2 and 58 months after radiosurgery. Recurrences occurred at a mean of 15.4 months from irradiation.
Time to the initial response
The time to response after radiosurgery was analyzed using the product limit method of Kaplan and Meier. The median time to achieving more than 50% pain relief (excellent, good or fair) was 2 months (2.0 ± 0.05), and median time to achieving complete pain relief (good or excellent) was also 2 months (2.0 ± 5.1). At 6 months after treatment, 81.4 (± 2.6)% of patients had achieved more than 50% pain relief, and by 12 months, 85.6 (±2.47)% (actuarial statistics). Complete pain relief (good or excellent) was achieved in 64.9 (± 3.2)% of the patients at 6 months, 70.3 (± 3.16)% by 1 year, and in 75.4 (± 3.49)% of patients by 33 months. Factors associated with time to response were determined by multivariate testing. The rate of achieving at least 50% relief was faster in patients with typical TN compared with patients who had additional atypical features (p ‫ס‬ 0.025). This factor was not significant for achieving complete pain relief (p ‫ס‬ 0.21). Other clinical factors were not significant in univariate or multivariate analyses.
Achievement of pain relief
Prior authors including our group noted a latency interval to pain relief of approximately 1 to 2 months. 2, 4, 9 In the present analysis, we found using actuarial statistics that 81.4 (± 2.6)% of patients responded to treatment within 6 months (median, 2 months). However, approximately 15% of patients had no improvement in their pain even after 12 months. Most patients would not wait so long to attain pain relief. Patients who have continued disabling pain after radiosurgery are managed with other surgical procedures. We advocate repeat radiosurgery only if initial complete pain relief had been achieved with subsequent recurrence.
Complete pain relief was achieved at a median time of 2 months (2.0 ± 5.1) with most patients achieving this level of relief within 6 months. Interestingly, a further 10% of patients achieved complete pain relief 6 to 33 months after radiosurgery. All of these patients obtained partial pain relief within 6 months, and a complete resolution of pain afterwards. It seems, therefore, that patients with partial pain relief may go on to complete relief over time. This finding provides some ideas regarding the mechanism of response to radiosurgery. Because most patients responded in the initial months, electrophysiologic blocking of ephaptic transmission after nerve irradiation, which has been discussed as a possible mechanism by some authors, 4,9 is possible. In contrast, because some patients responded or improved in a later phase (more than 6 months after radiosurgery), a later radiation effect with axonal degeneration may be present. The most important factor for a poor response to radiosurgery was the presence of atypical pain features in addition to the typical neuralgic pain. Only 43.8 ± 12.4% of patients with atypical pain features responded at 6 months, whereas 84.4 ± 2.6% patients with typical pain were relieved. Such patients usually report a constant dull or burning pain, or a tingling sensation in addition to the typical features of TN. Generally, these patients tend to be refractory to any other surgical procedures. Because these atypical features may be related to varying degrees of underlying nerve injury, a procedure that causes additional axonal affects may provide no benefit.
Maintenance of pain relief
The duration of pain relief after initial response in all patients was also analyzed using the product limit method of Kaplan and Meier. More than 50% pain relief (excellent, good or fair) was achieved and maintained in 75.8 ± 2.9% of patients at 1 year, 71.3 ± 3.3% of patients at 2 years, 67.2 ± 3.9% of patients at 3 years, 65.1 ± 4.3% of patients at 3.5 years, and 55.8% ± 9.3% of patients at 5 years. Complete pain relief (excellent or good) was achieved and maintained in 63.6 ± 3.3% of patients at 1 year, 59.2 ± 3.5% of patients at 2 years, 56.6 ± 3.8% of patients at 3 years and 37.7 ± 15.6% of patients at 5 years. The 5-year result does not reflect current practice since most patients with 5-year follow-up had radiosurgery at a lower dose (60-65 Gy) than presently used. A history of no prior surgery was the only factor significantly associated (p ‫ס‬ 0.01) with achieving and maintaining complete pain relief. The absence of preradiosurgery paresthesia (which is strongly correlated with no prior surgery) was significantly associated (p ‫ס‬ 0.024) with achieving and maintaining more than 50% pain relief. A history of no prior surgery was significant in univariate (p ‫ס‬ 0.0284) but not multivariate modeling (p ‫ס‬ 0.18) of achieving and maintaining more than 50% pain relief.
An analysis of the duration of pain relief first begins with an assessment of patients who failed to gain any benefit. Fifteen percent of patients did not obtain more than 50% pain relief and 25% did not obtain complete relief. For the entire series, 70% of patients achieved or maintained complete or more than 50% relief at 2 years, and 55% maintained the response 5 years after the time of the response. 10 The rate of achieving and maintaining complete pain relief was 60% at 2 years and 40% at 5 years. Pain recurred in 30 patients (13.6% of the entire series; recurrence after partial pain relief: 5 patients; recurrence after complete pain relief: 25 patients).
These results are not as good as those observed after a first MVD for typical tic douloureux. Barker et al., 12 in reporting on Jannetta's series of 1,185 patients, 13 found that complete pain relief was maintained in 70% of patients at 10 years. We continue to advocate MVD for appropriate younger patients with trigeminal neuralgia because of the potential for longer duration pain relief. Nevertheless, the possible risks of MVD make it unsuitable for some patients. In addition, the benefit of MVD is less when performed a second time, or for recurrent trigeminal neuralgia. We consider radiosurgery a good choice for patients with recurrent pain after MVD or percutaneous surgery has failed, even though prior surgical failure reduces the radiosurgical success rate.
Other investigators have reported long-term results after different percutaneous techniques for trigeminal neuralgia. Percutaneous retrogasserian thermal rhizotomy was first described in 1974 by Sweet and Wepsic 14 and has been performed widely. In Broggi's 15 series of 1,000 patients with 9.3 years of mean follow-up, they found an initial pain relief rate of 95%, with recurrence in 18.1%. Scrivani et al. 16 reported their series of 215 patients and found that 83% maintained pain relief at a mean interval of 32 months. Percutaneous retrogasserian glycerol rhizotomy, as initially reported by Håkanson, 17 is also widely used. Jho and Lunsford 18 reported that 90% of 523 patients achieved complete pain relief initially and that 77% maintained longer-term pain control, sometimes requiring multiple procedures. The pain recurrence rate was estimated to be between 30% and 50% over 2 to 10 years. Others reported a longer-term pain control rate of 50 to 90%. [19] [20] [21] After percutaneous trigeminal nerve balloon compression, Brown et al. 22 found that 94% of patients had initial pain relief but that pain recurred in 26%. Compared with percutaneous surgeries, the pain recurrence rate following radiosurgery seems to be less.
In our study, preoperative paresthesia and prior surgery were factors associated with duration of pain relief. Prior surgery may have injured the trigeminal nerve and caused a sensory disturbance. Seventy percent of patients without any prior surgery (n ‫ס‬ 85) maintained complete pain relief at 9 months and also at 5 years. We did not identify a recurrence in this group past 9 months. With this result, it is possible that primary radiosurgery could provide a high rate of long-term pain control, as is found after MVD. This will require further longer follow-up. However, in patients who had failed prior surgery, 60% of patients maintained complete pain relief at 1 year, 53% at 2 years, and 33% at 5 years (although those with 5 year follow-up had lower radiation doses). Considering that initial achievement of pain relief did not differ significantly between both groups (68% at 6 months and 76% at 1 year in patients with no prior surgery, vs. 63% at 6 months and 70% at 12 months in patients with prior surgery, p ‫ס‬ 0.42), the mechanism for achievement versus maintenance of pain relief may be different. Overall, statistics from second surgeries for trigeminal neuralgia are associated with poorer results than those from first surgeries, if performed correctly.
RADIOSURGICAL MORBIDITY
The low incidence of complications is the greatest advantage of stereotactic radiosurgery compared with all other surgeries. Paresthesia or numbness of varying magnitude is observed in 20% to 70% of patients after percutaneous thermorhizotomy, glycerol rhizotomy, or balloon nerve compression. 10, [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] In this study, 17 patients (10.2 ± 2.35% at 2 years) developed increased facial paresthesia and/or facial numbness. Only one patient (0.4%) developed deafferentation pain. This patient had recurrent TN previously treated by MVD. After her MVD she had some decrease in facial sensation, and her recurrent pain had some additional atypical features such as constant burning. Eight years after initial surgery, radiosurgery was performed to a maximum dose of 75 Gy using 2 isocenters. Eight months later, she developed increased constant burning pain with numbness consistent with deafferentation pain. The majority of our patients described their numbness or paresthesiae as minor and not bothersome. Some authors advocated percutaneous balloon nerve compression as advantageous for management of first division TN, because of the lower risk for postoperative corneal analgesia. 9, 22 In the present radiosurgery study no patient developed this complication. The reduced rate of facial sensory deficits or symptoms indicates that the effects on nerve tissue may be less than after other ablative surgeries. The effects of radiosurgery are likely a combination of both histologic and electrophysiologic responses.
Radiobiology of radiosurgery: a primate model of trigeminal nerve radiosurgery
Peripheral nerves are considered highly radioresistant and a dose that produces delayed radiation necrosis of spinal cord may have no effect on peripheral nerves. We studied the effects of radiosurgery on the trigeminal nerve using a baboon model. We delivered either 80 or 100 Gy to the nerve using a single 4-mm isocenter. 23 Trigeminal nerves that received 80 Gy radiosurgery had no inflammation. Focal myelin pallor and vacuolation without fibrosis was noted with Masson trichrome in the preganglionic nerve segments. Immunoreactivity for neurofilament showed substantial axonal loss, fragmentation, and some swellings. Plastic sections and ultrastructural studies showed a focal region near the center of the nerve exhibiting acutely degenerating axons, with preservation of some identifiable myelinated axons admixed with small foci of tissue necrosis. Schwann cell nuclei were also necrotic. The surrounding region contained only rare degenerating axons in which the trigeminal ganglia appeared normal, as did the distal nerve beyond the radiosurgery target.
Trigeminal nerves that received 100 Gy exhibited axonal degeneration with myelin vacuolation and expansion of the endoneurial intercellular matrix consistent with edema, and in one nerve, marked necrosis. The ganglion remained normal. On plastic sections, axonal degeneration was noted outside the necrotic zone, but the histology normalized toward the ganglion. Ultrastructural studies revealed that the axonal degeneration around the irradiated targets affected large and small myelinated axons similarly at both radiosurgery doses. Only rare intact unmyelinated axons were identified within and surrounding the major foci of nerve injury in both the 80 and 100 Gy groups. 23 The belief that radiosurgery might impact selectively on different fiber types (i.e., those conducting pain rather than light touch) was not found in our experiments. We could not detect a substantial difference in axonal injury among small myelinated, large myelinated, and unmyelinated fibers in this small sample. Through partial (focal) axonal degeneration, radiosurgery likely relieves trigeminal neuralgia pain by impacting upon an axon population large enough to result in pain relief. Conversely, the low incidence of lost facial sensation indicates that the remaining intact axonal population is enough to maintain neurologic function in the majority of patients. This balance between pain relief and preservation of sensation is important, and dependent on proper target and dose selection.
